Fundraising Fox
株式会社MOLCURE
Founded 2013 · 21 employees on LinkedIn · 5 known investors
Find your way into 株式会社MOLCURE
Sign up to see every warm intro you have to 株式会社MOLCURE
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社MOLCURE team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MOLCURE uses AI models trained on large experimental datasets to design molecules and accelerate drug discovery, working in collaboration with pharmaceutical partners. Its multidisciplinary team of machine learning scientists, biochemists, and bioinformaticians focuses on antibody and drug design.
Founders & leadership
株式会社MOLCURE was founded in 2013 by Satoshi Tamaki and Ryu Ogawa.
Investors · 5
How we know: GMO VenturePartners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: STRIVE's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: UTEC's portfolio page · Not right? Tell us
Frequently asked questions
- What does 株式会社MOLCURE do?
- MOLCURE uses AI models trained on large experimental datasets to design molecules and accelerate drug discovery, working in collaboration with pharmaceutical partners. Its multidisciplinary team of machine learning scientists, biochemists, and bioinformaticians focuses on antibody and drug design.
- Who founded 株式会社MOLCURE?
- 株式会社MOLCURE was founded by Satoshi Tamaki, Ryu Ogawa in 2013.
- Who are 株式会社MOLCURE's investors?
- 株式会社MOLCURE's investors include GMO VenturePartners, Japan Post Capital Co. Ltd., STRIVE, UTEC, JAFCO Group.